SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.605
AS - Asia 21.200
EU - Europa 11.405
SA - Sud America 3.359
Continente sconosciuto - Info sul continente non disponibili 794
AF - Africa 420
OC - Oceania 57
AN - Antartide 1
Totale 74.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.626
SG - Singapore 7.641
CN - Cina 5.000
BR - Brasile 2.641
VN - Vietnam 2.364
IT - Italia 2.320
DE - Germania 2.096
HK - Hong Kong 1.798
UA - Ucraina 1.771
TR - Turchia 1.289
BD - Bangladesh 1.041
GB - Regno Unito 1.022
FI - Finlandia 984
FR - Francia 787
RU - Federazione Russa 606
JP - Giappone 554
PL - Polonia 520
SE - Svezia 472
CA - Canada 467
IN - India 387
MX - Messico 342
ID - Indonesia 308
AR - Argentina 257
ZA - Sudafrica 174
NL - Olanda 168
IQ - Iraq 141
EC - Ecuador 117
ES - Italia 106
PK - Pakistan 102
CZ - Repubblica Ceca 98
BE - Belgio 94
CO - Colombia 87
UZ - Uzbekistan 78
AT - Austria 75
VE - Venezuela 75
CL - Cile 73
LT - Lituania 63
MY - Malesia 62
MA - Marocco 59
AE - Emirati Arabi Uniti 55
SA - Arabia Saudita 55
AU - Australia 50
PH - Filippine 50
TN - Tunisia 38
PY - Paraguay 35
KE - Kenya 33
JO - Giordania 30
PE - Perù 30
IL - Israele 29
EG - Egitto 27
RO - Romania 27
IE - Irlanda 26
CH - Svizzera 25
JM - Giamaica 24
NP - Nepal 23
BO - Bolivia 22
AZ - Azerbaigian 21
DZ - Algeria 21
OM - Oman 21
CR - Costa Rica 20
TH - Thailandia 20
DO - Repubblica Dominicana 19
ET - Etiopia 18
UY - Uruguay 18
AL - Albania 17
TT - Trinidad e Tobago 17
KZ - Kazakistan 16
RS - Serbia 16
KR - Corea 15
HN - Honduras 14
LV - Lettonia 14
BB - Barbados 13
HU - Ungheria 13
IR - Iran 13
PS - Palestinian Territory 12
EU - Europa 10
LB - Libano 10
PR - Porto Rico 10
BG - Bulgaria 9
HR - Croazia 9
NI - Nicaragua 9
PA - Panama 9
TW - Taiwan 9
YE - Yemen 9
DK - Danimarca 8
GT - Guatemala 8
SI - Slovenia 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
KG - Kirghizistan 7
PT - Portogallo 7
BH - Bahrain 6
GR - Grecia 6
MD - Moldavia 6
NG - Nigeria 6
QA - Qatar 6
SV - El Salvador 6
DM - Dominica 5
GE - Georgia 5
LY - Libia 5
Totale 73.949
Salva come PNG Salva come JPEG
Città #
Singapore 4.862
Ashburn 4.181
Fairfield 3.017
Woodbridge 2.971
San Jose 2.133
Houston 2.061
Jacksonville 1.869
Hong Kong 1.772
Chandler 1.675
Beijing 1.605
Santa Clara 1.527
Ann Arbor 1.362
Council Bluffs 1.249
Seattle 1.187
Wilmington 1.134
Cambridge 977
New York 734
Ho Chi Minh City 720
Los Angeles 652
Izmir 649
Nanjing 593
Dallas 591
Tokyo 535
Hanoi 520
Warsaw 488
Munich 482
Princeton 482
Lauterbourg 435
Helsinki 408
Milan 350
San Diego 314
Ferrara 312
Boardman 308
São Paulo 269
Shanghai 225
Mexico City 221
Jakarta 206
Shenyang 190
Toronto 185
Buffalo 184
Nanchang 172
Turku 171
Chicago 157
Orem 157
London 147
Rome 134
Dong Ket 132
Hebei 128
Montreal 122
Tianjin 121
Hefei 116
Bremen 115
Addison 113
Haiphong 111
Da Nang 110
Brooklyn 105
Changsha 101
Phoenix 101
Chennai 98
Denver 97
Rio de Janeiro 92
San Francisco 91
Brussels 90
Johannesburg 90
Moscow 90
Falls Church 88
Jiaxing 88
Dearborn 83
Frankfurt am Main 83
Atlanta 81
Bologna 77
Jinan 74
Zhengzhou 72
Stockholm 71
Mountain View 69
Tashkent 65
Redwood City 63
Biên Hòa 62
Brasília 60
Falkenstein 59
Baghdad 58
Manchester 57
Poplar 57
Guangzhou 56
Norwalk 55
Nuremberg 54
Boston 53
Belo Horizonte 52
Naples 52
The Dalles 52
Amsterdam 51
Brno 51
Curitiba 51
Lappeenranta 51
Hải Dương 48
Kunming 46
Mumbai 46
San Mateo 46
Quito 45
Washington 45
Totale 48.717
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 427
Delirium in acute promyelocytic leukemia patients: Two case reports 356
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 317
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 303
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 297
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 293
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 292
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 287
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 283
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 281
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 281
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 279
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 278
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 277
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 277
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 276
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 276
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 275
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 275
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 272
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 272
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 271
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 271
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 270
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 268
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 267
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 267
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 264
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 263
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 262
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 258
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 258
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 257
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 256
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 255
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 255
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 253
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 253
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 253
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 251
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 250
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 250
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 246
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 243
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 242
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 241
Early CP CML, Nilotinib 400 mg Twice Daily Frontline: Beyond 3 Years, Results Remain Excellent and Stable (A GIMEMA CML Working Party Trial) 240
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 239
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 238
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 238
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 235
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 234
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 234
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 234
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 232
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 230
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 230
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 229
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 229
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 229
Waldenstrom macroglobulinemia 229
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 228
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 228
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 228
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 227
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 226
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs 226
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 225
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 224
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 221
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 220
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 220
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 218
Burkitt’s lymphoma 217
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 217
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 217
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 217
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 214
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 214
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 213
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 212
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 212
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 211
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 210
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 210
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 209
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 209
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 209
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 209
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 208
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 206
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 206
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 205
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 204
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 204
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 204
Dendritic cells in acute promyelocytic leukaemia 203
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 203
Follicular lymphoma (FL) - updated. 202
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 202
Totale 24.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 346.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 42.700
Totale 388.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.005 0 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.065 499 178 137 462 698 592 181 362 560 21 250 125
2023/20242.038 186 284 97 50 128 281 88 111 65 55 79 614
2024/20259.387 315 199 785 324 1.143 743 242 510 1.535 1.223 1.262 1.106
2025/202629.115 2.375 1.384 2.433 3.783 3.804 1.827 2.985 1.533 2.801 3.240 1.652 1.298
2026/20272.568 1.145 1.423 0 0 0 0 0 0 0 0 0 0
Totale 74.841